Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

The penguin cap can help reduce hair loss in chemotherapy patients.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

MK-5108 is safe and shows potential against tumors, especially alone.

PPX causes much less hair loss than traditional taxanes.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

The treatment is safe and shows promise for metastatic breast cancer.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Aromatase gene variation may increase female hair loss risk.

The TrichoScan method effectively measures hair growth and helps choose patients for hair restoration surgery.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

A rare skin cancer was correctly diagnosed after surgery, highlighting the need for careful examination and follow-up.

Most Indian men aged 50-55 have a safe area for hair transplants, but selection should be careful to avoid overharvesting.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

A child's hair loss after Kawasaki disease may help understand the disease's autoimmune causes.